28

Jan

2025

16:00

GMT

Webinar

Could Acute COVID-19 Infection Ignite Thrombotic Risk?

00

Days

00

Hours

00

Mins

00

Secs

Reserve your Seat
Could Acute COVID-19 Infection Ignite Thrombotic Risk?

Faculty:


Naveed Sattar

Naveed Sattar


Philippe Gabriel Steg

Philippe Gabriel Steg


Lale Tokgözoğlu

Lale Tokgözoğlu


Joshua Stolker

Joshua Stolker

Reserve your Seat

Overview

Overview

Chaired by Prof Naveed Sattar (School of Cardiovascular and Metabolic Health, Glasgow, UK), Radcliffe Cardiology brings together a panel of distinguished experts, Prof Gabriel Steg (University Institute of France, Paris, FR), Prof Lale Tokgozoglu (Hacettepe University, Ankara, TR) and Dr Joshua Stolker (St Louis Hospital, Missouri, US) in this live roundtable broadcast to discuss their opinions on the thrombotic risk posed by acute infections. During this session, the panel will discuss and debate emerging data on the thrombotic risk associated with acute infections, including COVID-19 and the underlying mechanisms at play, identify patients at increased cardiovascular risk and discuss potential treatment approaches for these patients.

 


Z4-70169
DOP: October 2024

This non-promotional broadcast is initiated and funded by AstraZeneca. This broadcast is intended for healthcare professionals only.

Agenda and Learning Objectives

  • 11:00 - 11:05 – Introduction
  • 11:05 - 11:10 – Case Presentation: Demonstrating risk for thrombosis related to acute infection (MI/ACS?)
  • 11:10 - 11:20 – Mechanisms: Acute Infection to Thrombotic Risk
  • 11:20 - 11:25 – Discussion
  • 11:25 - 11:40 – What Does This Evidence Show: Current Overall Evidence and COVID-19 Then and Now
  • 11:40 - 11:55 Challenges to Practice – Case Discussion: Managing Increased Thrombotic Risk Related to Infection
  • 11:55 - 12:00 – Final Remarks
  • Identify patients at increased risk for thrombotic events associated with acute infections including COVID 19
  • Understand the mechanisms of increased thrombotic risk and the relationship to inflammation that may lead to plaque destabilisation and coagulation
  • Understand the challenges posed by emerging studies on COVID-19's thrombotic risk due to factors like vaccination and new variants
  • Discuss potential treatment approaches for patients with cardiovascular risk and acute infective episodes

Target Audience

  • Healthcare Professionals

Faculty Biographies


Naveed Sattar

Naveed Sattar

Prof Naveed Sattar is a distinguished Professor of Metabolic Medicine at the renowned Institute of Cardiovascular and Medical Sciences, University of Glasgow.

View full profile

Philippe Gabriel Steg

Philippe Gabriel Steg

Prof Philippe Gabriel Steg works as an Interventional Cardiologist and is Director of the Coronary Care Unit of Hôpital Bichat, in Paris, France. 

View full profile

Lale Tokgözoğlu

Lale Tokgözoğlu

S. Lale Tokgözoglu is Professor of Cardiology at Hacettepe University, Ankara, Turkey. She is currently the President of the European Atherosclerosis Society and Deputy Editor of the European Heart Journal.

View full profile

Joshua Stolker

Joshua Stolker

Dr Joshua M. Stolker is a distinguished cardiologist based in Saint Louis, Missouri, renowned for his exceptional expertise and compassionate patient care. 

View full profile